Shares are down by nearly half from their 2022 highs, in part due to repeated profit forecast cuts related to rising costs in ...

America’s largest drug store chain named a new chief executive officer on Friday, with longtime CVS Health executive David ...

Shares of the health care conglomerate dropped after the sudden departure of Karen Lynch and a downbeat update on the state ...

The pharma chain giant recently engaged strategic advisors about possibly breaking off its insurance and retail business.

CVS Health CEO Karen Lynch is stepping down after nearly four years at the helm, as the healthcare conglomerate faces ...

CVS Health on Friday replaced CEO Karen Lynch with David Joyner, a CVS veteran who retired before returning to the company ...

CVS Health stock sold for $72.08 a share when Karen Lynch became president and CEO in 2021. It closed at $60.35 on Friday.

CVS Health Corp. named David Joyner as its new chief executive officer, ending a tumultuous tenure for Karen Lynch at the ...

The move comes after the company repeatedly missed earnings targets, spurring activist interest and setting off unrest among ...

CVS Health replaced its top executive as it warned that its coming earnings will once again fall short of Wall Street ...

CVS has been struggling with rising medical costs in its Medicare Advantage plans and slumping drugstore sales.

CVS Health (CVS) announced a change in its chief executive officer and cautioned that its upcoming earnings are likely to ...